Drug Discovery
Vietnam to establish a manufacturing facility for Arcturus’ mRNA Covid-19 vaccine
Arcturus Therapeutics is a leading clinical stage company focused on messenger RNA (mRNA) medicines - one of the most advanced medicinal technologies in th...
August 03, 2021 | News
Insilico ,Westlake to jointly develop innovative small-molecule drugs for COVID19
The cooperation will be based on the anti-COVID-19 drug R&D project by Westlake Pharma, which aims to develop broad-spectrum small molecule inhibitor d...
August 03, 2021 | News
EC Healthcare, Prenetics to Pioneer the Future of Medicine
Under the collaboration, (i) EC Healthcare shall be the designated offline fulfillment partner of Prenetics online business; (ii) EC Healthcare shall ...
July 31, 2021 | News
Clarity commences theranostic prostate cancer trial
Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...
July 29, 2021 | News
VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant
New antiviral testing demonstrates SPL7013, the antiviral agent in VIRALEZE™ nasal spray, has potent virucidal activity against the globally signif...
July 28, 2021 | News
Collaborative Drug Discovery (CDD) Launches BioHarmony
Collaborative Drug Discovery, Inc. (CDD), provider of the web-based drug discovery informatics platform CDD Vault, announces the launch of a new data offer...
July 26, 2021 | News
Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack
Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its VITROS&...
July 23, 2021 | News
Parkinson's Implements CDD Vault to Manage Its Drug Discovery Data
The Parkinson's Virtual Biotech, which launched in 2017, is a program that is plugging the funding gap in drug development to fast-track the projects with ...
July 19, 2021 | News
Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant
Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threaten...
July 13, 2021 | News
Biological E to purchase CpG 1018 adjuvant from Dynavax
DYNAVAX AND BIOLOGICAL E ANNOUNCE COMMERCIAL SUPPLY AGREEMENT OF DYNAVAX’S CpG 1018 ADJUVANT FOR BIOLOGICAL E’S COVID-19 VACCINE CANDIDATE Dyn...
July 06, 2021 | News
Roche to drive therapies to treat breast and lung cancer
According to Globocan, in 2020 the global burden of cancer increased to 19.3 million new cases and 10 million deaths[1]. Worldwide, the most common type of...
July 06, 2021 | News
SINOMED announces a clinical collaboration with the National University of Ireland Galway
The PIONEER IV trial is a prospective, random trial that will take place in 30 hospitals across Europe, enrolling 2,540 patients and involve patient...
July 05, 2021 | News
Arctic Vision to develop innovative therapies for pan-ocular diseases
Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today...
July 05, 2021 | News
10x Genomics to Leverage Robust Single-Cell Technologies for Drug Development
To Support Global BioPharma Companies Leveraging Robust Single-Cell Technologies for Accelerated and Improved Drug Development Genuity Science, a ge...
June 28, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
